Agios Pharmaceuticals, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
US patents96
SAM.gov UEIKKWAB4MN58M3
CAGE code86WZ9
Incorporated inDE
LEI529900ONJHY8EOGYT555
- therapies
- rare diseases
- pyruvate kinase deficiency
- sickle cell disease
- cellular metabolism
- patient communities
- healthcare professionals
Named on the company’s own website, read JUL 29, 2026
Open positions
Openings read from Agios Pharmaceuticals, INC.’s own job board on Oracle Taleo, last checked OCT 24, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Senior Manager, Agios Clinical Educator (New York/Long Island)Agios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · Market Access · posted OCT 19, 2026
- Hemolytic Anemia Sales Specialist / Senior Hemolytic Anemia Sales Specialist (National)Agios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · Sales · posted OCT 14, 2026
- Sickle Cell Sales Specialist (Nashville)Agios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · Sales · posted OCT 6, 2026
- Senior Director, Chemical Development & Manufacturing, CMCAgios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · CMC · posted OCT 5, 2026
- Hemolytic Anemia Sales Specialist (Michigan)Agios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · Sales · posted SEP 30, 2026
- Hemolytic Anemia Sales Specialist (Pittsburgh)Agios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · Sales · posted SEP 30, 2026
- Hemolytic Anemia Sales Specialist (Nashville)Agios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · Sales · posted SEP 30, 2026
- Medical Director/Senior Medical Director, Clinical DevelopmentAgios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · Clin Dev · posted SEP 22, 2026
- Senior Manager, Corporate CommunicationsAgios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · Finance · posted SEP 22, 2026
- Sr. Manager/Associate Director, G&A Business Systems Analyst, ITAgios Pharmaceuticals, INC. · Agios Pharmaceuticals HQ · IT · posted AUG 27, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
96 US patents granted 2013–2025, 24 of them in the five years to SEP 2025.
Pharmaceuticals 75Organic fine chemistry 18Measurement 2
- Therapeutic compounds and compositionsUS 12,428,376 · granted SEP 30, 2025
- Pyruvate kinase activators for use in therapyUS 12,377,093 · granted AUG 5, 2025
- Pyruvate kinase activators for use in treating blood disordersUS 12,133,853 · granted NOV 5, 2024
- Pyruvate kinase activators for use in treating blood disordersUS 11,957,680 · granted APR 16, 2024
- Compounds and methods useful for stabilizing phenylalanine hydroxylase mutationsUS 11,919,915 · granted MAR 5, 2024
Newest 5 shown · Granted to Agios Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Agios Pharmaceuticals, INC. | Cambridge | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


